Copyright © 2021. Inderes Oyj. All rights reserved.

CellaVision

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
19.4.
2022

Today, CellaVision announced that the company's Annual and Sustainability Report for 2021 is available as PDF at www.cellavision.com and can be read via the link below.

The company has decided to print the 2021 Annual and Sustainability Report in a small number of copies in accordance with the company's environmental policy. To request a printed version, please visit the investor pages at CellaVision's website.

Tiedotteet
6.4.
2022

The shareholders of CellaVision AB (publ) reg. no. 556500-0998 (the “Company”) are hereby given notice of the Annual General Meeting (the “AGM”) on 11 May 2022 at 15.00 CEST in CellaVision’s premises at Mobilvägen 12 in Lund. Voting registration starts at 14.30 CEST and continues until the opening of the AGM.

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail.

Right to participate

Tiedotteet
25.2.
2022

Ahead of the Annual General Meeting (AGM) 2022 the Nomination Committee of CellaVision AB proposes that the number of Board members for the period until the next AGM shall be five, with no alternates.

Muut analyysit
7.2.
2022

Redeyes view on the Q4 report. We make minor adjustments to our estimates for 2022, with a slightly lower growth assumption. We adjust our Base case to SEK 340 (330) per share with an unchanged fair value range.

Tiedotteet
4.2.
2022

Updated market penetration rate on page 3 in the report

1 October-31 December 2021

Muut analyysit
4.2.
2022

Redeyes's first comments on the Q4 report earlier this morning.

Tiedotteet
4.2.
2022

1 October-31 December 2021

Tiedotteet
21.1.
2022

CellaVision AB (publ) will publish the Year-end bulletin for 2021, on February 4, 2022 at 7:20 CET

The report will be available at www.cellavision.com

In connection with the release of the year-end bulletin analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Simon Østergaard, President & CEO, will present and comment the report.

Tiedotteet
13.1.
2022

CellaVision’s Chief Financial Officer (CFO), Magnus Blixt has informed that he will leave his position as CFO of CellaVision, to take on the position as CEO of the medical technology company Dignitana AB. Magnus will continue to support CellaVision until mid-April 2022.

Muut analyysit
22.10.
2021

Redeyes's first comments on the Q3 report earlier this morning.

CellaVision